ArticleImmunoTargets and therapy2025

Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer.

Kai Nan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.